Kobo Biotech Ltd

Kobo Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kobo Biotech Ltd

₹ 2.74 -2.14%
22 Nov - close price
avonlifesciences.com BSE: 531541
About

Kobo Biotech is engaged in the business of Pharmaceutical products.

[ add key points ]
Website BSE
  • Market Cap ₹ 6.53 Cr.
  • Current Price ₹ 2.74
  • High / Low ₹ 6.01 / 2.66
  • Stock P/E
  • Book Value ₹ -55.8
  • Dividend Yield 0.00 %
  • ROCE -52.9 %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.27 0.70 0.30 9.24 0.34 0.21 0.17 0.79 0.23 0.20 0.20 0.25 0.34
Operating Profit -0.27 -0.70 -0.30 -9.24 -0.34 -0.21 -0.17 -0.79 -0.23 -0.20 -0.20 -0.25 -0.34
OPM %
0.02 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.02
Interest 0.00 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 1.35 1.03 1.04 1.18 1.15 0.89 1.03 1.00 1.01 1.02 1.03 1.01 1.01
Profit before tax -1.60 -1.86 -1.34 -10.42 -1.47 -1.10 -1.20 -1.79 -1.22 -1.22 -1.23 -1.26 -1.33
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
-1.60 -1.86 -1.35 -10.42 -1.47 -1.10 -1.19 -1.79 -1.23 -1.22 -1.23 -1.26 -1.33
EPS in Rs -0.67 -0.78 -0.57 -4.37 -0.62 -0.46 -0.50 -0.75 -0.52 -0.51 -0.52 -0.53 -0.56
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
170.15 56.89 29.05 32.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
134.40 61.34 38.51 27.74 4.05 3.02 1.72 0.69 2.79 10.51 1.50 0.88 0.99
Operating Profit 35.75 -4.45 -9.46 4.80 -4.05 -3.02 -1.72 -0.69 -2.79 -10.51 -1.50 -0.88 -0.99
OPM % 21.01% -7.82% -32.56% 14.75%
0.22 0.18 2.60 0.42 6.00 0.04 -2.15 0.03 0.04 0.02 0.02 0.02 0.02
Interest 17.21 18.14 15.62 14.37 14.41 14.50 14.44 14.47 10.84 0.13 0.00 0.00 0.00
Depreciation 9.97 9.62 7.78 7.31 6.78 6.44 6.15 5.88 5.64 4.61 4.07 4.07 4.07
Profit before tax 8.79 -32.03 -30.26 -16.46 -19.24 -23.92 -24.46 -21.01 -19.23 -15.23 -5.55 -4.93 -5.04
Tax % 5.92% 1.69% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
8.27 -32.57 -30.26 -16.46 -19.24 -23.92 -24.46 -21.01 -19.23 -15.23 -5.55 -4.93 -5.04
EPS in Rs 3.68 -14.48 -13.45 -6.94 -8.08 -10.04 -10.27 -8.82 -8.07 -6.39 -2.33 -2.07 -2.12
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: 6%
5 Years: 12%
3 Years: 20%
TTM: 5%
Stock Price CAGR
10 Years: -13%
5 Years: 14%
3 Years: -15%
1 Year: -8%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 22.50 22.50 22.50 23.73 23.83 23.83 23.83 23.83 23.83 23.83 23.83 23.83
Reserves 54.64 22.07 -8.83 -17.30 -42.41 -66.33 -90.79 -111.80 -131.03 -146.25 -151.81 -156.74
131.49 136.99 142.42 152.68 207.60 221.96 236.36 250.76 260.53 140.71 139.84 139.69
69.01 97.45 95.74 101.36 63.20 66.48 70.04 73.54 77.26 60.89 63.47 64.61
Total Liabilities 277.64 279.01 251.83 260.47 252.22 245.94 239.44 236.33 230.59 79.18 75.33 71.39
107.77 103.52 95.10 87.79 81.01 74.56 68.42 62.54 56.91 41.66 37.59 33.52
CWIP 2.92 2.25 2.25 2.25 2.25 2.25 2.25 2.25 2.25 0.00 0.00 0.00
Investments 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19 12.19 0.00 0.00 0.00
154.76 161.05 142.29 158.24 156.77 156.94 156.58 159.35 159.24 37.52 37.74 37.87
Total Assets 277.64 279.01 251.83 260.47 252.22 245.94 239.44 236.33 230.59 79.18 75.33 71.39

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
38.42 11.02 19.32 5.62 32.30 31.47 20.95 14.48 2.51 93.76 0.87 0.20
-8.42 -4.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 25.09 0.00 0.00
-35.76 -7.00 -20.50 -5.27 -32.76 -31.47 -20.95 -14.47 -1.08 -120.28 -0.87 -0.15
Net Cash Flow -5.76 -0.69 -1.18 0.35 -0.46 0.00 0.00 0.00 1.43 -1.43 0.00 0.05

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 156.49 419.02 705.62 1,006.50
Inventory Days 207.82 585.06 896.42 1,038.63
Days Payable 96.88 404.72 659.54 1,092.57
Cash Conversion Cycle 267.42 599.37 942.51 952.56
Working Capital Days 197.93 571.21 829.89 821.19
ROCE % 13.15% -7.12% -10.18% -1.33% -2.77% -5.11% -4.49% -3.94% -5.31% -17.60% -36.82% -52.90%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95% 44.95%
0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66% 0.66%
54.39% 54.39% 54.39% 54.39% 54.39% 54.39% 54.39% 54.40% 54.39% 54.39% 54.37% 54.39%
No. of Shareholders 5,6115,6455,8626,0646,0646,2046,2046,4966,4586,4786,5306,767

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports